AS091 - A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results

Journal article

Open access

Peer reviewed

Pietro Lampertico, Maria Buti, Alnoor Ramji, Scott Fung, Sang Hoon Ahn, Wan-Long Chuang, Seung Kew Yoon, Jia-Horng Kao, Chi-Yi Chen, Edward Tam, …

Journal of hepatology, v 73, pp S67-S68

Aug 2020

Files and links (2)

url

https://doi.org/10.1016/s0168-8278(20)30670-xView

Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze), Open

url

https://doi.org/10.1016/S0168-8278(20)30670-XView

Published, Version of Record (VoR) Open

17 Record Views

Title: AS091 - A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results
Creators: Pietro Lampertico
Maria Buti
Alnoor Ramji
Scott Fung
Sang Hoon Ahn
Wan-Long Chuang
Seung Kew Yoon
Jia-Horng Kao
Chi-Yi Chen
Edward Tam
Mandana Khalili
Ho Bae
Xiaoli Ma
Won Young Tak
John F. Flaherty
Anuj Gaggar
Vithika Suri
Susanna Tan
Yang Liu
George Wu
Mani Subramanian
Hie-Won Hann
Kosh Agarwal
Young-Suk Lim
Henry Chan
Publication Details: Journal of hepatology, v 73, pp S67-S68
Publisher: Elsevier
Resource Type: Journal article
Language: English
Academic Unit: Medicine (Graduate)
Other Identifier: 991019170449804721